Why Dr. Martens Shares Tumbled on Thursday

Shares in Dr. Martens (LON: DOCS) tumbled sharply on Thursday, sliding as much as 8% intraday to a low of 79p before closing at 79.23p — down 7.4% on the day — as the bootmaker was caught in the fallout from a brutal profit warning at rival JD Sports.

The trigger came before markets opened, when JD Sports Fashion released its Q2 2026/27 trading statement, cutting full-year profit guidance to £700m-£800m from a previous £750m-£850m range. The retailer reported group organic sales down 1.3%, against consensus expectations for 0.5% growth, while like-for-like sales fell 3.1%.

The real shock, however, was North America, where like-for-like sales collapsed 6.8% — dramatically worse than the 0.6% decline analysts had pencilled in. JD Sports blamed weaker consumer sentiment, slowing demand for footwear, and delayed back-to-school spending. Its own shares crashed 15% on the news.

That North American demand signal spooked investors in Dr. Martens, whose turnaround story — built on a 61% jump in adjusted pre-tax profit reported in June — leans heavily on growth in the Americas. The read-across concern was compounded by Dr. Martens’ existing exposure to US tariffs, which forced the company to raise US prices from January 2026. Weakening consumer demand makes those price hikes riskier just as the brand tries to protect margins.

With no company-specific news from Dr. Martens itself, Thursday’s slide was a clear case of sector contagion, as JD Sports’ warning reset sentiment across UK footwear retail.